Lumateperone for the Improvement of Apathy in Patients With Psychotic Symptoms.

NCT06482554 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Apathy
Schizophrenia
Schizophrenia; Psychosis

Interventions

DRUG: Lumateperone 42 mg
DRUG: Risperidone 2 mg

Sponsor

Louisiana State University Health Sciences Center Shreveport